Anti-SHP1 antibody [EPR5519]
- 20ul selling size
- KO Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(13 Publications)
Rabbit Recombinant Monoclonal SHP1 antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 13 publications.
View Alternative Names
HCP, PTP1C, PTPN6, Tyrosine-protein phosphatase non-receptor type 6, Hematopoietic cell protein-tyrosine phosphatase, Protein-tyrosine phosphatase 1C, Protein-tyrosine phosphatase SHP-1, SH-PTP1, PTP-1C
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-SHP1 antibody [EPR5519] (AB124942)
Immunocytochemistry/Immunofluorescence analysis of Raji (human Burkitt's lymphoma) cells labelling SHP1 with purified ab124942 at a dilution of 1/500. Cells were fixed with 4% Paraformaldehyde and permeabilised with 0.1% tritonX-100. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (ab150077) at dilution of 1/1000 was used as the secondary antibody. Nuclei counterstained with DAPI (blue).
Secondary Only Control : PBS was used instead of the primary antibody as the negative control.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-SHP1 antibody [EPR5519] (AB124942)
Intracellular Flow Cytometry analysis of Jurkat (Human T cell leukemia T lymphocyte) cells labeling SHP1 with purified ab124942 at 1/100 dilution (10μg/mL) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cells without incubation with primary antibody and secondary antibody (Blue).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SHP1 antibody [EPR5519] (AB124942)
ab124942, at a 1/1000 dilution, staining SHP1 in paraffin-embedded Human tonsil tissue by immunohistochemistry
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-SHP1 antibody [EPR5519] (AB124942)
Lanes 1 - 4 : Merged signal (red and green). Green - ab124942 observed at 70 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37 kDa.
ab124942 was shown to react with SHP1 in wild-type THP-1 cells in Western blot with loss of signal observed in PTPN6 knockout sample. Wild-type THP-1 and PTPN6 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab124942 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-SHP1 antibody [EPR5519] (ab124942) at 1/1000 dilution
Lane 1:
Wild-type THP-1 cell lysate at 20 µg
Lane 2:
PTPN6 knockout THP-1 cell lysate at 20 µg
Lane 2:
Western blot - Human PTPN6 knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-ptpn6-knockout-thp-1-cell-line-ab273717'>ab273717</a>)
Lane 3:
Jurkat cell lysate at 20 µg
Lane 4:
K562 cell lysate at 20 µg
Predicted band size: 68 kDa
Observed band size: 70 kDa
false
- WB
Lab
Western blot - Anti-SHP1 antibody [EPR5519] (AB124942)
Western blot : Anti-SHP1 antibody [EPR5519] ab124942 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 68 kDa in Wild-type MCF7 cell lysates with no signal observed at this size in PTPN6 CRISPR-Cas9 Edited MCF7 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween 20 (TBS-T) before incubation with primary antibodies overnight at 4 C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-SHP1 antibody [EPR5519] (ab124942) at 1/1000 dilution
Lane 1:
Wild-type MCF7 at 20 µg
Lane 2:
Western blot - Human PTPN6 knockout MCF7 cell line (ab287732) at 20 µg
Lane 3:
THP-1 at 20 µg
Lane 4:
SH-SY5Y at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 68 kDa
Observed band size: 68 kDa
false
- WB
Unknown
Western blot - Anti-SHP1 antibody [EPR5519] (AB124942)
All lanes:
Western blot - Anti-SHP1 antibody [EPR5519] (ab124942) at 1/1000 dilution
Lane 1:
Jurkat cell lysate at 10 µg
Lane 2:
Raji cell lysate at 10 µg
Lane 3:
lymph node lysate at 10 µg
Secondary
All lanes:
standard HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 68 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-SHP1 antibody [EPR5519] (AB124942)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
- WB
CiteAb
Western blot - Anti-SHP1 antibody [EPR5519] (AB124942)
SHP1 western blot using anti-SHP1 antibody [EPR5519] ab124942. Publication image and figure legend from Saidova, A., Potashnikova, D. M., et al., 2017, Cancer Med, PubMed 29125235.
ab124942 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab124942 please see the product overview.
Protein expression level of BCR components in B‐CLL ZAP70‐high and ZAP70‐low representative cases. (A) Immunoblot of signaling tyrosine kinases in ZAP70‐low sample (sample 1) and ZAP70‐high sample (sample 2), histone H3 was taken as a technical control. (B) Sample 1 (see A) analyzed by flow cytometry. Median fluorescence intensities of Zap70 in B‐CLL and T‐cell populations differ ×2.85‐fold; MFI(Zap70)T‐cells/MFI(Zap70)B‐CLL = 2.85. (C) Sample 2 (see A) analyzed by flow cytometry. Median fluorescence intensities of Zap70 in B‐CLL and T‐cell populations do not differ. MFI(Zap70)T‐cells/MFI(Zap70)B‐CLL = 1.
false
Related conjugates and formulations (3)
-
Anti-SHP1 antibody [EPR5519] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-SHP1 antibody [EPR5519]
-
578 PE
PE Anti-SHP1 antibody [EPR5519]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
SHP1 influences cell proliferation survival and differentiation by acting as a negative regulator of signaling pathways. It is not a part of a larger protein complex but it associates transiently with different receptors and substrates. It plays an important role in the immune response by regulating cytokine signaling which is important for maintaining the balance between immune activation and tolerance.
Pathways
SHP1 significantly impacts the JAK/STAT and B cell receptor signaling pathways. In the JAK/STAT pathway SHP1 interacts with JAK kinases contributing to the downregulation of cytokine signaling. In B cell receptor signaling it associates with Syk influencing immune cell activation and function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:11025 PubMed40164665
2025
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 19:20240991 PubMed39091610
2024
Applications
Unspecified application
Species
Unspecified reactive species
EMBO molecular medicine 16:1755-1790 PubMed39030302
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology, immunotherapy : CII 73:69 PubMed38430268
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:798445 PubMed35127714
2022
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 9:362 PubMed33842583
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology international 44:1811-1819 PubMed32374464
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 43:1659-1668 PubMed32323811
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of clinical and experimental 11:5612-5621 PubMed31949648
2018
Applications
Unspecified application
Species
Unspecified reactive species
Cell & bioscience 8:50 PubMed30202514
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com